Efficacy and safety of novel carbapenem–β-lactamase inhibitor combinations: Results from phase II and III trials

OBJECTIVES: The addition of novel β-lactamase inhibitors to carbapenems restores the activity against multidrug-resistant Gram-negative bacteria. The aim of this study was to summarize the evidence on the efficacy and safety of novel carbapenem–β-lactamase inhibitor combinations. METHODS: We conduct...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Wei, Shen, Ping, Luo, Qixia, Xiong, Luying, Xiao, Yonghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538188/
https://www.ncbi.nlm.nih.gov/pubmed/36211957
http://dx.doi.org/10.3389/fcimb.2022.925662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538188/
https://www.ncbi.nlm.nih.gov/pubmed/36211957
http://dx.doi.org/10.3389/fcimb.2022.925662

Ejemplares similares